Detection of Epstein-Barr virus in leucoreduced blood products

Vox Sanguinis

Volumn 110, Issue 2, 2016, Pages 199-201

  Trottier, H ^a   Delage, G ^b   Hu, J ^a   Robitaille, N ^a   Buteau, C ^a   Tucci, M ^a   Lacroix, J ^a   Alfieri, C ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b HÉMA QUÉBEC   (Canada)

Author keywords

Herpesviruses; Immunosuppression; Leucoreduction; Transfusion; Transplant

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD STORAGE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ERYTHROCYTE CONCENTRATE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; LEUKAPHERESIS; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; VIRUS DETECTION; VIRUS GENOME; BLOOD CELL; ISOLATION AND PURIFICATION; STANDARDS; STATISTICS AND NUMERICAL DATA; VIROLOGY;

BLOOD BANKS; BLOOD CELLS; HERPESVIRUS 4, HUMAN; HUMANS; PLASMA;

EID: 84958608309     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12330     Document Type: Article

References (12)

1. Hema-Québec. Safety measures in place. http://www.hema-quebec.qc.ca/comprendre/mesures-de-securite/securite-en-place.en.html. Accessed May 6, 2015.
2. Csire M, Mikala G: Human herpesviruses in hematologic diseases. In Magel GD, Tyring S (ed): Herpesviridae - A Look Into This Unique Family of Viruses ISBN: 978-953-51-0186-4, InTech, 2012. Available from: http://www.intechopen.com/books/herpesviridae-a-look-into-this-unique-family-ofviruses/human-herpesviruses-in-hematologic-diseases
3. Cohen JI: Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 1991; 70:137-160
4. Singh N: Infections with Human Herpesvirus 6, 7, and 8 after hematopoietic stem cell or solid organ transplantation; in: Bowden R, Ljungman P, Paya C (eds): Transplant Infections, 2nd edn.Philadelphia, Lippincott Williams & Wilkins, 2003.
5. Hudnall SD, Chen T, Allison P, et al.: Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion 2008; 48:1180-1187
6. Wagner HJ, Kluter H, Kruse A, et al.: Determination of the number of Epstein-Barr virus genomes in whole blood and red cell concentrates. Transfus Med 1995; 5:297-302
7. Qu L, Xu S, Rowe D, et al.: Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells. Transfusion 2005; 45:591-595
8. Qu L, Rowe DT, Donnenberg AD, et al.: Effects of storage and leukoreduction on lymphocytes and Epstein-Barr virus genomes in platelet concentrates. Transfusion 2009; 49:1580-1583
9. Lefevre J: Real-time PCR assays using internal controls for quantitation of HPV-16 and beta-globin DNA in cervicovaginal lavages. J Virol Methods 2003; 114:135-144
10. Decker LL, Klaman LD, Thorley-Lawson DA: Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 1996; 70:3286-3289
11. Patel P, Tuke P, Tettmar K, et al.: No evidence of transfusion transmission of Adenovirus and Epstein-Barr virus infections in paediatric recipients post-bone marrow transplant. Vox Sang 2015; 109:95-97
12. Trottier H, Buteau C, Robitaille N, et al.: Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children. Transfusion 2012; 52:2653-2663